Form D · Private Equity Fund

Advent Life Sciences Fund II LP

London, X0 · CIK 0001614918

Offering snapshot reported Nov 3, 2014 · SEC filing

Reported sold
$226M
Offering amount: $226M
Investors reported
15
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 9, 2014
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$113M$226MSep 10, 2014: $146,331,726.00Sep 10, 2014Nov 3, 2014: $226,271,136.00Nov 3, 2014

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$146,331,726 → $226,271,136
  • Reported investors13 → 15

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 3, 2014Amendment$226,271,136$79,939,410vs Sep 10, 201415SEC filing
Sep 10, 2014Initial$146,331,726No comparison13SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
06b, 3C, 3C.1, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-224448
Amounts have been converted from British Pounds Sterling to US Dollars at a value of ?1 to $1.6107 based on rates posted by Retuers on 10/27/14 at 9:14 a.m. EDT.

Source: Form D, filed Nov 3, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ADVENT LIFE SCIENCES FUND II LP

Investment adviser: ADVENT LIFE SCIENCES LLP

Gross asset value
$159M
Beneficial owners
15
ADV minimum commitment
$4.5M

Reported in Form ADV on Mar 26, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Auditor KPMG LONDON, United Kingdom
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
No
Administrator other than the adviser
No
External marketing
No

KPMG
PCAOB 1119

Filing source

Form ADV 2072193 · Mar 26, 2026 · Schedule D 7.B.(1), fund 805-3053351816

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Advent Life Sciences Llp Executive, Promoter
Advent Ls Ii Lp Promoter
Kaasim Mahmood Executive
Shahzad Malik Executive
Rajesh Parekh Executive
Dale Pfost Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
158 160 North Gower Street
London, X0, NW1 2ND